维普期刊资源整合服务平台（V6.5）

133篇 您的检索式：作者名="Foley JE"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	A high concentration of fasting plasma non -esterified fatty acids is a risk factor for the development of NIDDM 显示文摘	Paolisso G Tataranni PA Foley JE	1995	Diabetologia1995，38，：	1
2	Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience显示文摘	Foley JE Jordan J	2010	Vasc Health Risk Manag2010，6，3：	1
3	Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately control ed with a sulphonylurea显示文摘	Garber AJ Foley JE Banerji MA		0，，：	1
4	Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-Ⅳ inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year 显示文摘	Ahren B Pacini G Foley JE	2005	Diabetes Care2005，28，8：	1
5	An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of phase II and III clinical trials 显示文摘	Ligueros-Saylan M Foley JE Schweizer A	2010	Diabetes Obes Metab2010，12，6：	1
6	Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 yesr显示文摘	Ahren B Padni G Foley JE	2005	Diabetes Care2005，28，8：	1
7	Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-Ⅳ inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year显示文摘	Ahrén B Paeini G Foley JE	2005	Diabetes Care2005，28，8：	1
8	Effects of vilda- gliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea 显示文摘	Garber AJ Foley JE Banerji MA	2008	Diabe-tes Obes Metab2008，10，11：	1
9	The regulation of glucose transport by c AMP stimulators via three different mechanisms in rat and human adipocytes显示文摘	Kashiwagi A Huecksteadt TP Foley JE	1983	J Biol Chem1983，258，13：	1
10	Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately control ed with a sulphonylurea显示文摘	Garber AJ Foley JE Banerji MA		0，，：	1
11	The ecology of tick-transmitted infections in the redwood chipmunk (Tamias ochrogenys ) 显示文摘	Foley JE Nieto NC	2011	Ticks Tick Borne Dis2011，2，2：	1
12	Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea显示文摘	Garber AJ Foley JE Banerji MA	2008	Diabetes Obes Metab2008，10，11：	1
13	Vildagliptin in drug-naive patients with type 2 diabetes: A 24-week, double-blind, randomized, placebo-controlled, multiple-dose study 显示文摘	Dejager S Razac S Foley JE	2007	Horm Metab Res2007，39，3：	1
14	Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas显示文摘	Zeldin D Foley CJ Boyle JE	1997	Endocrinology1997，138，3：	1
15	Alpha cell function in health and disease:influence of glucagon-like peptide-1显示文摘	Dunning BE Foley JE Ahren B	2005	Diabetologia2005，48，9：	1
16	Insulin action in obese non-insulin-dependent diabetics and in their isolated adipocytes before and after weight loss显示文摘	Zawadzki JK Bogardus C Foley JE	1987	Diabetes1987，36，2：	1
17	Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin显示文摘	Ahren B Foley JE Bosi E	2011	Diabetes Obes metab2011，13，：	1
18	Beta-cell function in mild type 2 diabetic patients: effects of 6 - month glucose lowering with nateglinide 显示文摘	Mari A Gastaldelli A Foley JE	2005	Diabetes Care2005，28，5：	1
19	Th2 cell therapy of estab lished acute graft versus-hostdisease requires IL-4 and IL-10 and is abrogated by 1L-2 or host-type antigen-presenting cells显示文摘	Foley JE Mariotti J Ryan K	2008	Biol Blood Marrow Transplant2008，14，9：	1
20	CD3/CD28-costimulated T1 and T2 subsets:differential in vivo allosensitization generates distinct GVL and GVHD effects显示文摘	Jung U Foley JE Erdmann AA	2003	Blood2003，102，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示